Higher ANA Titers Linked to Increased Risks of Infertility and Miscarriage – Fertility Plus
Fertility Plus shared a post on LinkedIn:
“ANA in IVF
Recent research by Yoshihara et al. (2025) offers key insights into anti-nuclear antibodies (ANA) in reproductive health. They determined that low-titer ANA (≤1:160) does not significantly impact live birth rates, suggesting a threshold where these antibodies may become clinically relevant. Conversely, higher ANA titers have previously been linked to increased risks of infertility and miscarriage.
This study emphasizes the importance of monitoring ANA levels in pregnancy planning and highlights the need for further research into how these antibodies influence reproductive outcomes. Understanding these thresholds can empower couples during their fertility journeys.
Association between antinuclear antibodies and pregnancy prognosis in recurrent pregnancy loss patients Open Access
H Yoshihara, S Goto, Tamao Kitaori, M Sugiura-Ogasawara
Human Reproduction, Volume 40, Issue 2, February 2025, Pages 236–243.”
Stay updated on all scientific advances in the field of fertility with Fertility News.
-
May 1, 2026, 10:52Magdalena Depa-Martynow: Dogmas, Dilemmas, and Psychological Safety in IVF
-
May 1, 2026, 10:47Spring 2026 RBMO Digest Brings Together Key Papers and Editor-Selected Articles
-
May 1, 2026, 10:13Fewer Cells for PGT-A Testing Can Be Just as Reliable and Gentler on Your Future Baby – Fertility Plus
-
May 1, 2026, 10:08Prabhleen Kaur: Can Vitamin B12 Improve Egg and Embryo Quality?
-
May 1, 2026, 03:13International Expert Recommendations in Emerging Reproductive Science – ESHRE
-
Apr 30, 2026, 18:45AI in Ultrasound Follicular Monitoring Moves Toward Clinical Decision Support – RBMO
-
Apr 30, 2026, 11:42ASRM Encourages Registration for Conference on Practice Growth and Innovation
-
Apr 30, 2026, 11:26ESHRE and ALPHA Launch Global Survey to Update ART Laboratory KPIs
-
Apr 30, 2026, 11:10Susanne Johnson: Advanced Gynaecology Ultrasound Course Day 2